Antimetabolite Chemotherapy (C1516020)
|Definition (NCI)||Treatment of cancer that utilizes antimetabolite substances to disrupt DNA, RNA, or protein synthesis.|
|Concepts||Pharmacologic Substance (T121)|
|English||Chemotherapy, Antimetabolites, Chemotherapy, Cancer, Antimetabolites, Antimetabolite Chemotherapy|
Derived from the NIH UMLS (Unified Medical Language System)
You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.
If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.
Please Contact Me as you run across problems with any of these versions on the website.
©2022, Family Practice Notebook, LLC
Patients should address specific medical concerns with their physicians.
Although access to this page is not restricted, the information found here is intended for use by medical providers.
This page was written by Scott Moses, MD, last revised on 10/21/2007 and last published on 10/29/2022
This is one of 7137 pages in the Family Practice Notebook